Volume 1, Emitir 2 (2011)
Perspectiva Terapêutica
Novel treatment strategies for patients with nonalcoholic fatty liver disease
Brian Lam,Zobair M Younossi
Artigo de Revisão
Diagnosis and treatment of prostate cancer-related bone disease
Tilman Todenhoefer, Georgios Gakis, David Schilling, Gerhard Feil, Christian Schwentner,Arnulf Stenzl
Artigo de Revisão
Tyrosine kinase inhibitors in differentiated thyroid arcinoma: a review of the clinical evidence
Hendrieke C Hoftijzer, Ellen Kapiteijn2, Tatiana, Schneider, Guido C Hovens, Hans Morreau, Hans Gelderblom, Johannes WA Smit
Artigo de Revisão
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Artigo de Revisão
Cladribine in the treatment of multiple sclerosis
Karen Schreiber, Per Soelberg Sorensen
Artigo de Revisão
Emerging treatments for small-cell lung cancer: Phase II and III trials
Joel W Neal, Matthew A Gubens, Heather A Wakelee
Artigo de Revisão
Clinical efficacy and safety of moroctocog alfa
Emanuela Marchesini, Domenico Prisco, Alfonso Iorio
Artigo de Revisão
Velaglucerase alfa in the treatment of Gaucher disease type 1
Thomas A Burrow, Gregory A Grabowski
Artigo de Revisão
Tocilizumab for rheumatoid arthritis: results of the Phase III clinical trial program
Javier Rueda, Miguel A Gonzlez-Gay, Ricardo Blanco
Artigo de Revisão
Eltrombopag for the treatment of chronic immune thrombocytopenia
Stavroula Tsiara, Nichola Cooper
Perspectiva Terapêutica
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
